Reckitt announces FDA approval of Mucinex Cold & Fever
The product is the first OTC cold/flu medication to provide 12-hour relief from fever, cough, chest congestion, and body pain; it is now available at retailers nationwide.
See the latest news and media coverage for Reckitt. We track all announcements, press releases, and industry mentions in real time, all in one place.
Consumer health, hygiene and nutrition company
reckitt.comLast updated
In short: Reckitt delivered strong quarterly sales growth driven by emerging markets, launched a £500m buyback, and expanded its presence in China.
The product is the first OTC cold/flu medication to provide 12-hour relief from fever, cough, chest congestion, and body pain; it is now available at retailers nationwide.
H1 LFL net revenue growth of 2.7%, adjusted operating margin ahead of expectations, and full-year outlook reiterated.
The transaction is expected to complete in H2 2026, representing c.1% of net revenue.
The facility in Caohejing Hi-Tech Park is Reckitt's largest R&D investment in Asia.
Reckitt announced today a milestone for the cold and flu category and the company: Mucinex® 12HR Cold & Fever Multi-Symptom is the first U.S. Food...
Russia’s largest canmaker Arnest Group will acquire the Russian Hygiene business of UK-based Reckitt-Benckiser Group, which will be joining other global companies that have dismantled...
Household goods giant Reckitt Benckiser has said it is increasing prices in the UK and worldwide in the face of rising costs amid the Iran...
Reckitt Benckiser Group PLC RKT Stock: Get the latest price, growth trends, performance insights, and sustainability analysis to make informed investment decisions.
Track Reckitt and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Reckitt and other trending companies.